Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-04-08
1984-03-27
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424309, 424319, 424263, A61K 31275, A61K 3124, A61K 31195, A61K 3144
Patent
active
044394454
ABSTRACT:
The present invention provides a method for gastrointestinal cytoprotection using a class of oxamic acids and derivatives thereof.
REFERENCES:
patent: 4137325 (1979-01-01), Sellstedt et al.
patent: 4152448 (1979-05-01), Wardell
patent: 4186127 (1980-01-01), Hall et al.
Lancaster Cleo
Robert Andre
The Upjohn Company
Waddell Frederick E.
Welch Lawrence T.
LandOfFree
Cytoprotective use of oxamate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoprotective use of oxamate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoprotective use of oxamate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755775